 Co-Diagnostics Inc NASDAQ: CODX shares are trading higher in Thursdays after-hours session after the company reported financial results and issued earnings guidance. Co-Diagnostics reported full year 2021 revenue of 97.89 million, which is up 23.3 million year-over-year. 